share_log
Breakings ·  Oct 29 19:03
Invivyd Inc: Preliminary Q3 2024 Pemgarda™ (Pemivibart) Net Product Revenue of $9.3 Mln
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment